| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Molecular Biotechnology [P. S. N., K. W., L. G., L. H.], Medicine [P. S. N., S. R. P.], Pathology [L. T.], and Urology [A. Y. L.], University of Washington, Seattle, Washington 98195, and Department of Pathology, Medical College of Virginia, Richmond, Virginia 23298 [J. L. W.]
Hevin, a gene closely related to the extracellular matrix protein SPARC, is an acidic cysteine-rich glycoprotein shown to be important for the adhesion and trafficking of cells through the endothelium. Through the use of differential display and differential EST analysis, we identified Hevin as a gene whose transcription is down-regulated in transformed prostate epithelial cell lines and metastatic prostate adenocarcinoma. These results were confirmed by comparing expression levels between normal and neoplastic human prostate tissues using Northern analysis. In situ hybridization with an 35S-labeled antisense riboprobe demonstrated the loss of Hevin expression in metastatic prostate carcinoma. The expression pattern of Hevin in transformed and metastatic epithelium may provide further insights into the complex cell adhesion events involved in the metastatic progression of prostate carcinoma.
1 This work was supported by the CaPCURE Foundation and the Lucas Foundation.
2 To whom requests for reprints should be addressed, at the Department of Molecular Biotechnology, Box 357730, HSB K-360, University of Washington, Seattle, Washington 98195.
Received 10/ 9/97. Accepted 12/ 1/97.
This article has been cited by other articles:
|
|
 |
|
  D M Peehl Primary cell cultures as models of prostate cancer development Endocr. Relat. Cancer, March 1, 2005; 12(1): 19 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Brekken, M. M. Sullivan, G. Workman, A. D. Bradshaw, J. Carbon, A. Siadak, C. Murri, P. E. Framson, and E. H. Sage Expression and Characterization of Murine Hevin (SC1), a Member of the SPARC Family of Matricellular Proteins J. Histochem. Cytochem., June 1, 2004; 52(6): 735 - 748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. O. Hambrock, D. P. Nitsche, U. Hansen, P. Bruckner, M. Paulsson, P. Maurer, and U. Hartmann SC1/Hevin. AN EXTRACELLULAR CALCIUM-MODULATED PROTEIN THAT BINDS COLLAGEN I J. Biol. Chem., March 21, 2003; 278(13): 11351 - 11358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Shridhar, J. Lee, A. Pandita, S. Iturria, R. Avula, J. Staub, M. Morrissey, E. Calhoun, A. Sen, K. Kalli, et al. Genetic Analysis of Early- versus Late-Stage Ovarian Tumors Cancer Res., August 1, 2001; 61(15): 5895 - 5904. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. K. Yiu, W. Y. Chan, S.-W. Ng, P. S. Chan, K. K. Cheung, R. S. Berkowitz, and S. C. Mok SPARC (Secreted Protein Acidic and Rich in Cysteine) Induces Apoptosis in Ovarian Cancer Cells Am. J. Pathol., August 1, 2001; 159(2): 609 - 622. [Abstract] [Full Text]
|
|
|
|
|
|
V. Luzzi, V. Holtschlag, and M. A. Watson Expression Profiling of Ductal Carcinoma in Situ by Laser Capture Microdissection and High-Density Oligonucleotide Arrays Am. J. Pathol., June 1, 2001; 158(6): 2005 - 2010. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Moler, M. L. Chow, and I. S. Mian Analysis of molecular profile data using generative and discriminative methods Physiol Genomics, December 18, 2000; 4(2): 109 - 126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Thomas, L. D. True, J. A. Bassuk, P. H. Lange, and R. L. Vessella Differential Expression of Osteonectin/SPARC during Human Prostate Cancer Progression Clin. Cancer Res., March 1, 2000; 6(3): 1140 - 1149. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
